130274-01-0Relevant academic research and scientific papers
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.
Hellberg, Mark R,Conrow, Raymond E,Sharif, Najam A,McLaughlin, Marsha A,Bishop, John E,Crider, Julie Y,Dean, W Dennis,DeWolf, Kevin A,Pierce, David R,Sallee, Verney L,Selliah, Robert D,Severns, Bryon S,Sproull, Steven J,Williams, Gary W,Zinke, Paul W,Klimko, Peter G
, p. 2031 - 2049 (2010/12/01)
A series of prostaglandin DP agonists containing a 3-oxa-15-cyclohexyl motif was synthesized and evaluated in several in vitro and in vivo biological assays. The reference compound ZK 118.182 (9beta-chloro-15-cyclohexyl-3-oxa-omega-pentanor PGF(2alpha)) i
Synthesis of a chemically and metabolically stable and biologically potent PGD2-analogue
Buchmann,Skuballa,Vorbruggen
, p. 3425 - 3428 (2007/10/02)
The metabolic labile α-chain of the PGD2-analogue 2 (ZK 110841) can be stabilized by introduction of an β-oxygen-atom resulting in 3 (ZK 118182), which has a much higher and longer lasting biological activity on oral application in rats. The synthetic methodology for the synthesis of 3-oxa-Z-Δ5,6-prostaglandins will be discussed.
